Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
10 studies found for:    "smith-magenis syndrome"
Show Display Options
Rank Status Study
1 Active, not recruiting Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)
Condition: Smith Magenis Syndrome
2 Recruiting Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances
Condition: Sleep Disturbances in Smith-Magenis Syndrome
Intervention: Other: Data collection of sleep disturbances in individuals with SMS
3 Recruiting Natural History Study of Smith-Magenis Syndrome
Conditions: Chromosome Abnormalities;   Smith Magenis Syndrome
4 Completed Melatonin Levels in Smith Magenis Syndrome (SMS)
Condition: Chromosome Disorders
Interventions: Dietary Supplement: Melatonin;   Device: Enviro-light artificial light box
5 Recruiting Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS
Conditions: Smith-Magenis Syndrome;   Circadian
Intervention: Drug: tasimelteon
6 Recruiting Treatment Strategies for Children With Smith-Magenis Syndrome
Conditions: Developmental Delay Disorders;   Chromosome Deletion;   Mental Retardation;   Sleep Disorders, Circadian Rhythm;   Self Injurious Behavior
Interventions: Drug: dTR Melatonin (NIH CC PDS);   Device: Phototherapy (Bright Light);   Drug: Melatonin CR
7 Recruiting Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents
Conditions: Circadian Rhythm Sleep Disorders;   Non-24 Hour Sleep-Wake Disorder;   Autism Spectrum Disorder;   Smith-Magenis Syndrome
Intervention: Drug: tasimelteon
8 Completed Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
Conditions: Williams Syndrome;   Angelman Syndrome;   Prader-Willi Syndrome;   Shprintzen Syndrome;   Smith-Magenis Syndrome;   DiGeorge Syndrome;   Chromosome Abnormalities
9 Completed Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances
Condition: Sleep Problems
Interventions: Drug: Circadin 2 mg;   Drug: Circadin 10 mg
10 Active, not recruiting Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities
Condition: Sleep Disorders
Interventions: Drug: Circadin 2/5/10 mg;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.